Cognitive decline · Older people living in the community
3 findings from 1 review
no estimate extracted
3 studies · 4617 participants
High
no estimate extracted
6 studies · 8697 participants
Moderate
no estimate extracted
2 studies · 1554 participants
Very low
All‐cause mortality · Older people living in the community
Multi‐domain interventions showed no clear difference in mortality compared with usual care/placebo (high certainty).
1 finding from 1 review
Multiple pregnancy rate · women undergoing assisted reproduction
It is very uncertain whether dopamine agonist plus co‐intervention changes multiple pregnancy rate compared with co‐intervention (very low certainty).
1 finding from 1 review
Miscarriage · women undergoing assisted reproduction
Dopamine agonist plus co‐intervention showed no clear difference in miscarriage rate compared with co‐intervention (low certainty).
1 finding from 1 review
Any other adverse events · women undergoing assisted reproduction
It is very uncertain whether dopamine agonist plus co‐intervention changes any other adverse events compared with co‐intervention (very low certainty).
1 finding from 1 review
Moderate or severe OHSS · women undergoing assisted reproduction
Dopamine agonist plus co‐intervention may leads to lower incidence of moderate or severe OHSS compared with co‐intervention (low certainty).
1 finding from 1 review
Live birth rate · women undergoing assisted reproduction
Dopamine agonist plus co‐intervention showed no clear difference in live birth rate compared with co‐intervention (low certainty).
1 finding from 1 review
Clinical pregnancy rate · women undergoing assisted reproduction
Dopamine agonist plus co‐intervention showed no clear difference in clinical pregnancy rate compared with co‐intervention (low certainty).
1 finding from 1 review
Emotionalism (primary outcome) · emotionalism after stroke
It is very uncertain whether pharmaceutical interventions changes emotionalism (primary outcome) compared with placebo (very low certainty).
1 finding from 1 review
Emotionalism: mean scores at end of treatment ‐ Pathological Laughter and Crying Scale · emotionalism after stroke
1 finding from 1 review
Depression: Mean scores at end of treatment · emotionalism after stroke
1 finding from 1 review
Cognitive function · emotionalism after stroke
1 finding from 1 review
Activities of daily living · emotionalism after stroke
1 finding from 1 review
Adverse events: 1. death: at end of treatment · emotionalism after stroke
Pharmaceutical interventions showed no clear difference in adverse events: 1. death: at end of treatment compared with placebo (moderate certainty).
1 finding from 1 review
Activities of daily living · stroke survivors with hearing, smell, and taste perception disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Psychological and mental health · stroke survivors with somatosensory perception disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Perception · stroke survivors with somatosensory perception disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · stroke survivors with somatosensory perception disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Activities of daily living · stroke survivors with tactile perception disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Extended activities of daily living · stroke survivors with tactile perception disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found